Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cornu aspersum snail extract is a complex biologic derived from the mucus of the garden snail *Cornu aspersum* (formerly *Helix aspersa*). It contains a diverse array of bioactive components, including allantoin, glycolic acid, glycosaminoglycans like hyaluronic acid, and various antimicrobial peptides and glycoproteins. The extract exhibits multifaceted therapeutic potential, including antibacterial activity against Gram-positive and Gram-negative pathogens, promotion of cell proliferation and migration for wound healing, and neuroprotective effects in models of Alzheimer's disease. Research is primarily conducted by academic institutions in Bulgaria, Greece, and Ukraine, focusing on applications for chronic wounds, burns, and neurodegeneration. While widely used in the cosmetic industry, its development as a standardized pharmaceutical product is currently in the early research stages.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cornu aspersum snail extract.